ERBB2 and breast cancer: Based on the presence/absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor-2 (Her2), BC patients can be classified into the following categories: luminal A, luminal B, HER2 overexpression, and triple-negative subtypes.